Recruiting Ulcerative Colitis Studies in Rome
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
The purpose of this study is to assess the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of satralizumab, a humanized anti-interleukin-6 receptor (aIL-6R) monoclonal antibody, in a...
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
This is a multicenter, open-label, non-randomized study to investigate the safety, tolerability, and efficacy of a single intravenous (IV) infusion of SGT-003 in participants with Duchenne muscular dy...
About Ulcerative Colitis Clinical Trials in Rome
Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.
There are currently 2 ulcerative colitis clinical trials recruiting participants in Rome, GEORGIA. These studies are seeking a combined 90 participants. Research is being sponsored by Hoffmann-La Roche, Solid Biosciences Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ulcerative Colitis Clinical Trials in Rome — FAQ
Are there ulcerative colitis clinical trials in Rome?
Yes, there are 2 ulcerative colitis clinical trials currently recruiting in Rome, GEORGIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Rome?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rome research site will contact you about next steps.
Are clinical trials in Rome free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rome studies also compensate for your time and travel.
What ulcerative colitis treatments are being tested?
The 2 active trials in Rome are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.
Data updated March 2, 2026 from ClinicalTrials.gov